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MicroRNAs (miRNAs) are inhibitors of gene
expression capable of controlling processes in
normal development and cancer. In mammals,
miRNAs use a seed sequence of 6–8 nucleo-
tides (nt) to associate with 30 untranslated re-
gions (30UTRs) of mRNAs and inhibit their ex-
pression. Intriguingly, occasionally not only the
miRNA-targeting site but also sequences in its
vicinity are highly conserved throughout evolu-
tion. We therefore hypothesized that conserved
regions in mRNAs may serve as docking plat-
forms for modulators of miRNA activity. Here
we demonstrate that the expression of dead
end 1 (Dnd1), an evolutionary conserved RNA-
binding protein (RBP), counteracts the function
of several miRNAs in human cells and in primor-
dial germ cells of zebrafish by binding mRNAs
and prohibiting miRNAs from associating with
their target sites. These effects of Dnd1 are me-
diated through uridine-rich regions present in
the miRNA-targeted mRNAs. Thus, our data un-
ravel a novel role of Dnd1 in protecting certain
mRNAs from miRNA-mediated repression.
INTRODUCTION
MicroRNAs (miRNAs) constitute a family of 22 nucleo-
tide (nt) RNAs widely expressed in metazoans (Lee et al.,
1993; Pillai et al., 2007). These regulators of gene expres-
sion are capable of defining and altering cell fate. Recent
estimations suggest the existence of 500–1000 miRNAs
per genome and that a large proportion of human pro-
tein-coding genes are under the regulation of one or
more miRNAs (Aravin and Tuschl, 2005; Lewis et al.,
2005). Evidence suggests that miRNAs participate in theCellregulation of a large variety of cellular processes and
that the vast majority of miRNAs show tissue or develop-
mental stage-specific expression (Lagos-Quintana et al.,
2002; Lim et al., 2005;Wienholds et al., 2005). Importantly,
aberrant expression or activity of miRNAs can lead to dis-
ease (Kloosterman and Plasterk, 2006; Pillai et al., 2007;
Voorhoeve and Agami, 2006).
Most miRNAs are transcribed by RNA polymerase II as
long RNAs that are converted to70-nt-long pre-miRNAs
by Drosha (Lee et al., 2003). The pre-miRNAs are then
exported to the cytoplasm by Exportin 5, converted to
22 nt mature miRNAs by Dicer, and one strand of the
duplex is incorporated into the RNA-induced silencing
complex (RISC) (Gregory et al., 2005;Maniataki andMour-
elatos, 2005). In animals, miRNAs utilize a seed sequence
at their 50 end (nt 2–8) to associate with 30UTR regions of
mRNAs to suppress gene expression by inhibiting transla-
tion that occasionally is associated with mRNA decay
(Bagga et al., 2005; Lim et al., 2005; Pillai et al., 2005).
RepressedmRNAs, miRNAs, andmost proteins constitut-
ing the miRNA-RISC complex (miRNP) are enriched in
cytoplasmic processing bodies called P bodies. P bodies
are known to be sites of translational repression and
mRNA decay. They are enriched in factors involved in
inhibition of translation and lack ribosomes and transla-
tion-initiation factors (Liu et al., 2005; Pillai et al., 2005).
Importantly, it is becoming increasingly clear that during
their biogenesis, the activity of miRNAs is subjected to in-
tense regulation. For example, the nuclear processing of
certain miRNAs (e.g., let-7 in ES cells) can be repressed
by a yet unknown mechanism (Thomson et al., 2006). Fur-
thermore, certain miRNAs are modified by RNA editing,
a process that can lead to changes in miRNA stability or
alter their target selection (Kawahara et al., 2007; Knight
and Bass, 2002; Yang et al., 2006). Additionally, two
recent reports indicated that miRNA-mediated repression
in neurons is reversible. Treatment of cultured rat neurons
with brain-derived neurotrophic factor leads to partial
relief of Limk1 mRNA repression by miRNA-134 (Schratt131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc. 1273
Figure 1. Dnd1 Counteracts the Inhibition of p27 Expression by miR-221
(A) Conservation analysis of p27-30UTR from human to fish (from Kent et al. [2002]). The positions of the two target sequences of miR-221 are marked.1274 Cell 131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc.
et al., 2006). This process possibly involves the mTOR
pathway, although the mechanism of miRNA derepres-
sion remains unknown. Second, external stimulation of
Drosophila olfactory neurons induces degradation of the
Armitage protein, which is required for miRNP assembly
(Ashraf et al., 2006). As a result, the translation of the
protein kinase CaMKII mRNA, which is controlled by
miRNAs, is enhanced. Last, the repression of CAT-1
mRNA by miR-122 in hepatocarcinoma cells is relieved
in stress conditions by binding of HuR, an AU-rich ele-
ment-binding protein, to a region at the end of the 30UTR
of CAT-1 (Bhattacharyya et al., 2006).
In addition, evidence in zebrafish suggests that, a subset
of miR-430 targets is protected from repression in germ
cells (Mishima et al., 2006). In particular,miR-430-mediated
repression of nanos1 and TDRD7 is not effective in germ
cells. As specific regions in the 30UTRof these genescoun-
teract their repression in germline cells, it is reasonable to
assume that germ cell-specific factors bind and counter-
act miR-430 function in these cells. Germ cells are known
to contain structures referred to as germplasm that resem-
ble P bodies; these contain an array of RNA-binding pro-
teins (RBPs) giving these cells unique control over transla-
tion and the stability of mRNA and proteins (Kotaja et al.,
2006; Kotaja and Sassone-Corsi, 2007). Together, these
observations indicate that themiRNApathwaycanbecon-
trolled at different levels, from stability, processing, se-
quence identity, and binding to target mRNAs. Here we
show that theRBPdead end1 (Dnd1) prohibitsmiRNA-de-
pendent inhibition of gene expression in humancells and in
zebrafish primordial germ cells.
RESULTS
Dnd1 Relieves miRNA Repression
in Human Germline Cells
Using functional genetic-screening approaches, we have
recently identified themiRNA-mRNA interactions between
p27 and miR-221 and between LATS2 and miR-372 as
promoting cancer (le Sage et al., 2007; Voorhoeve et al.,
2006). Both p27 and LATS2 harbor at their 30UTR two
nearby evolutionary conserved target sequences for
miRNA-221 or -372, respectively, that are required and
sufficient for miRNA function (Figures 1A, S1A, andCeS1B). Interestingly, in both cases the conservation was
not restricted to the miRNA-targeting sequences, but
rather included the whole region in between the two
miRNA-targeting sites. This observation suggests that
other factors (proteins or RNA) could associate with these
regions to influence miRNA/mRNA function and/or inter-
action. To investigate the possibility that RBPs influence
the activity of themiRNA pathway, we examined the effect
of expression of several RBPs on miR-221-mediated
repression of p27. We utilized a reporter assay with the
wild-type 30UTR of p27 coupled to luciferase and mea-
sured miRNA-induced repression. We found that human
dead end 1 (Dnd1), a protein whose function is required
for germ cell survival andmigration in zebrafish (Weidinger
et al., 2003), affects miRNA activity. Specifically, cotrans-
fection of Dnd1 diminished miR-221-mediated inhibition
of luciferase-p27-30UTR expression (Figure 1B). Dnd1
had no effect on expression from either a construct
encoding luciferase-p27 30UTR that is mutated at the
two miR-221 sites or on an empty luciferase reporter vec-
tor, suggesting that the increase in luciferase expression
was not caused by a general effect on transcription or
translation efficiency but rather was specific to miRNA-
repressed translation. Similar results were obtained with
LATS2/miR-372 and connexin-43/miR-1 and -206 (Fig-
ure S1C). To further test whether Dnd1 activity depends
on miRNA function we inactivated miRNA synthesis with
an shRNA vector targeting Pasha, a component specific
to the miRNA pathway (Gregory et al., 2004). Figure S1D
demonstrates the inhibitory effect of shPasha on miR-
221 processing. In HEK293 cells, which endogenously ex-
press p27 and miR-221 (Figure 2C), introduction of Dnd1
or inhibition of Pasha, elevated endogenous p27 protein
levels to a comparable extent (4-fold, Figure 1C). Inter-
estingly, cointroduction of Dnd1 and shPasha did not
cause further elevation in p27 levels, further supporting
the idea that Dnd1 activity depends on miRNA function.
Dnd1 contains a conserved RNA-binding domain that
bears high similarity to that of apobec complementation
factor (ACF), LOC166863, Syncrip, hnRNPR, ELAV4, and
DAZ. To test whether the effect of Dnd1 on miRNA activity
is specific and mediated through its RNA-binding domain,
we used expression plasmids of Dnd1 homologs and
related genes and found neither to significantly inhibit(B) Expression vectors for miR-221 and human Dnd1 (huDnd1) were cotransfected with the indicated luciferase constructs. Relative luciferase activity
is the ratio between firefly luciferase and renilla control luciferase, adjusted to 100%. An immunostaining with anti-HA antibody demonstrates the
expression of huDnd1 while H2B-GFP was used to control transfection efficiency. The results are represented as means and SD from three indepen-
dent experiments.
(C) HEK293T cells were transfected with the indicated constructs and whole-cell lysates were immunostained with anti-Tubulin, p27, and HA anti-
bodies. p27 protein level was analyzed using Tina 2.0 software (Raytest, Sheffield, UK).
(D and E) Similar to (B), only that several RBPs, as well as the zebrafish Dnd1 homolog (drDnd1) and a mutant in the RNA-binding domain
(drDnd1Y104C), were cotransfected together with pGL3-p27-30UTR and renilla luciferase control.
(F) HEK293T cells were transfected with the indicated constructs and subjected to RPA with probes to detect p27 mRNA and control cyclophilin and
to immunoblot analysis using p27 and control Tubulin antibodies. Quantification of protein levels was performed using Tina 2.0 software (Raytest;
Sheffield, UK).
(G) Tera1 cells were transfected with shDnd1 and subjected to quantitative RT-PCR analysis for LATS2, Dnd1, and GAPDH control. The results are
represented as means and SD from three independent experiments.
(H) Similar to (B), Tera1 cells were transfected with the indicated constructs.ll 131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc. 1275
Figure 2. Dnd1 Preferentially Associates with mRNAs
(A) MCF-7 cells were transfected with the indicated constructs and subjected to subcellular fractionation to separate nuclear from cytoplasmic
material, and both protein and RNA were extracted. RPA was performed with probes to detect miR-221 and cyclophilin. Immunoblot analysis
was performed with HA antibodies to demonstrate expression of Dnd1 and to detect Cdc6 and Tubulin, to test the purity of fractionation. P is probes
alone, Y is yeast total RNA.
(B) Expression vectors for miR-221 and human Dnd1 (huDnd1) were cotransfected with the indicated luciferase constructs and proceeded as in
Figure 1B. Blue and brown bars represent control and Dnd1 vectors, respectively.
(C) HEK293 cells were cotransfected with the indicated expression constructs and subjected to IP with anti-HA antibodies. RNA was extracted from
80% of each IP and 5% from each input and subjected to RPA analysis to detect p27 and control cyclophilin mRNAs, human telomerase RNA (hTR),
and miR-221. Below, a blow up of p27 signal in control and wild-type IP samples is shown for clarity.
(D) The same amount of extracts from input and IP (marked T and IP, respectively) was used for immunoblot analysis with anti-HA and control anti-
Tubulin antibodies.miR-221-mediated suppression of luciferase-p27 30UTR
(Figure 1D, expression controls shown in Figure S1E). In
contrast, repression of miR-221 activity was observed
also when the zebrafish and mouse homologs of Dnd1
were introduced (Figure 1E and data not shown). Interest-
ingly, transfection of a zebrafish Dnd1 mutated at a single
conserved residue within its RNA-binding domain (Y104C,
a mutant that cannot rescue loss of germ cells when Dnd1
is depleted in zebrafish embryos; K.S and E.R., unpub-
lished data) hampered Dnd1’s ability to inhibit miR-221
function (Figure 1E). Also substituting the RNA-binding
domain of Dnd1 for that of ACF resulted in loss of Dnd1
function (Figure S1F). Collectively, these results suggest
that inhibiting miRNA function is specific to Dnd1 and indi-1276 Cell 131, 1273–1286, December 28, 2007 ª2007 Elseviecate that for counteracting miRNA activity, Dnd1 requires
an intact RNA-binding domain.
Suppression of gene expression by miRNAs is exerted
by translational inhibition that occasionally is associated
withmRNAdecay (Baggaet al., 2005; Limet al., 2005; Pillai
et al., 2005). To test the possible effect of Dnd1 on these
pathways, we examined the endogenous p27 RNA and
protein levels in HEK293 cells (expressing endogenous
p27 and miR-221and -222, Figure 2C). Figure 1F shows
that transfection of either human or wild-type zebrafish
Dnd1, but not the Y104C mutant, caused elevation in p27
mRNA (up to 1.5-fold) and protein (up to 5-fold), indicating
that Dnd1 can potently block endogenous miR-221 and
-222-mediated mRNA decay and translation inhibition.r Inc.
In all our experiments so far we examined the function of
human Dnd1 by ectopic introduction. To study endoge-
nous Dnd1 function, we first tested by quantitative RT-
PCR several human cancer cell lines for the expression
of Dnd1 and found the teratoma Tera1 cell line to be pos-
itive. Interestingly, Tera1 cells express high levels of the
miR-372 family, which we have previously shown to target
LATS2 through two sites at its 30UTR (Figure S1B). We
therefore examined endogenous LATS2 expression in
Tera1 cells following suppression of Dnd1 expression by
an effective shRNA vector (Figure S1G). As Dnd1 affected
both miRNA-mediated translation inhibition and mRNA
stability (Figure 1F), we used quantitative RT-PCR and
found a marked reduction in LATS2 mRNA levels associ-
ated with the inhibition of endogenous Dnd1 expression
(Figure 1G), suggesting that Dnd1 protects LATS2 expres-
sion. To directly measure the effect of endogenous Dnd1
on the activity of endogenous miR-372 family, we used
sensor molecules containing the luciferase gene under
the control of either wild-type LATS2-30UTR or a mutant
in the 372 target sites (le Sage et al., 2007; Voorhoeve
et al., 2006). Figure 1H shows that transfection of shDnd1,
but not a control vector, reduced the expression of a
cotransfected luciferase LATS2 30UTR reporter gene
only when the miR-372 targeting sites were present.
Altogether, these results indicate that endogenous Dnd1
in Tera1 cells protects the expression of endogenous
LATS2 from being targeted by the miR-372 family.
Preferential Association of Dnd1 with mRNAs
Since Dnd1 requires an intact RNA-binding domain to
counteract miRNA function, it is conceivable that Dnd1 in-
terfereswitheither theexpression, theprocessing tomature
miRNA, or the subcellular localizationofmiR-221. To exam-
ine the effects of Dnd1onmiR-221biogenesis,MCF-7 cells
were cotransfected with vectors encoding either human or
zebrafish Dnd1 andmiR-221 or control miRNA, and subse-
quently subjected to subcellular fractionation, RNA isola-
tion, and to an RNase protection assay (RPA) to detect cy-
clophilin control RNA and miR-221 precursor and mature
forms. As shown in Figure 2A, the expression level, effi-
ciency of processing, or subcellular localization of mature
miR-221 were not altered by Dnd1. Western blot analysis
with anti-HAconfirmed the expressionof humanand zebra-
fishproteins,whereasnuclearCdc6andcytoplasmicTubu-
lin verified cellular fractionation (Figure 2A, bottom).
An alternative explanation that could account for Dnd1
activity is that the protein binds miRNAs and inhibits their
function. To test this option we converted one miR-221-
targeting site in p27 30UTR to an RNAi site (named FC,
a full complementary region to miR-221) and mutated
the seed of the second site (Figure 2B). In this way,
p27-30UTR FC was solely subjected to RNAi-mediated
degradation by miR-221. In cotransfection assays, the
presence of Dnd1 did not reduce miR-221 activity toward
p27-30UTR FC, suggesting that Dnd1 was unable to coun-
teract the RNAi pathway. These results are in line with the
assumption that Dnd1 counteracts miR-221 activity eitherCell 1at the level of RISC-incorporated-mature miR-221 or
downstream, rather than by steric hindrance of miR-221.
Next, we checked whether Dnd1 interacts with mature
miR-221 or with p27 30UTR. We transfected HEK293 cells
with HA-tagged Dnd1, Dnd1Y104C, and as controls HA-
tagged PAK4 and empty vector. We also cotransfected
an expression vector for miR-221 to enhance the possible
association with Dnd1. Subsequently, we subjected
whole-cell extracts to immunoprecipitation (IP) using
anti-HA antibodies, extracted RNA, and performed RPAs
to detect the interactingRNAs. This analysis revealed clear
binding of Dnd1 to endogenous p27 and cyclophilin
mRNAs but not to hTR, a nontranslated-RNA coding for
human telomerase RNA (Figure 2C) (Kedde et al., 2006).
The interaction of Dnd1 with p27 and cyclophilin required
its intact RNA-binding capacity, as no apparent interaction
was observedwith theDnd1Y104Cmutant. Furthermore, no
specific association was detected with miR-221, even
when itwascotransfectedwithDnd1. Immunoblot analysis
with HA antibody confirmed the expression and equal
immunoprecipitation of Dnd1 and PAK4 (Figure 2D). Alto-
gether, these results demonstrate that Dnd1 bindsmRNAs
but not miRNAs to block miRNA activity.
Dnd1 Alleviates miR-430 Repression of Nanos1
and TDRD7 in Primordial Germ Cells of Zebrafish
We next examined the function of Dnd1 in zebrafish to
question whether the relief of mRNA-mediated repression
described above is part of the in vivo function of Dnd1 in
the context of a developing organism. Whereas Dnd1
has been shown to be essential for germline development
in zebrafish andmouse, the actual molecular mechanisms
by which it exerts its function are unknown (Weidinger
et al., 2003; Youngren et al., 2005). We followed the
expression changes of three germline specific genes:
nanos1, TDRD7, and Vasa. The specific expression of
nanos1 and TDRD7 in the PGCs is considered to be the
result of miR-430-dependent inhibition in somatic cells,
while Vasa regulation is miR-430 independent (Mishima
et al., 2006). Indeed, mutating the single miR-430 site in
the 30UTR of either nanos1 or TDRD7 results in ubiquitous
expression. However, while PGCs allow nanos1 and
TDRD7 expression, they also express miR-430, suggest-
ing that miR-430-induced repression of these genes is
suppressed in PGCs (Mishima et al., 2006).
To study Dnd1 function, we knocked down the transla-
tion of the gene in zebrafish embryos using morpholino
antisense oligonucleotides. RNA was extracted from
these embryos, and the endogenous levels of the germ-
line-specific genes (nanos1, TDRD7, and Vasa) were com-
pared to Odc1, a ubiquitously expressed gene. In line with
our hypothesis, the inhibition of endogenous Dnd1 caused
a marked reduction in endogenous nanos1 and TDRD7
mRNA levels, but not Vasa (Figures 3A and S2A). Then,
we cloned the 30UTRs of nanos1, TDRD7, and control
Vasa downstream of fluorescencemarker genes, to deter-
mine whether the Dnd1 effect is mediated through their
30UTR. Similar to the endogenous expression pattern,31, 1273–1286, December 28, 2007 ª2007 Elsevier Inc. 1277
Figure 3. Zebrafish Dnd1 (drDnd1) Counteracts Inhibition of Nanos by miR-430
(A) One-cell-stage zebrafish embryos were injected with Dnd1 morpholino or control morpholino. RNA was extracted and subjected to quantitative
RT-PCR analysis to compare endogenous levels of nanos1 and vasa to odc, and nanos to vasa.
(B) One-cell-stage zebrafish embryos were coinjected with DsRed-nos1-30UTR and gfp-vasa-30UTR together with dead end morpholino or control
morpholino.1278 Cell 131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc.
the injection of RNA, encoding a fluorescent marker gene
fused to the 30UTR of nanos1, TDRD7, or Vasa, into zebra-
fish embryos leads to preferential fluorescence in PGCs
(Koprunner et al. [2001] and data not shown). Upon
Dnd1 knockdown, quantitative pixel-intensity analysis
shows a clear and significant reduction in red fluorescent
signal (DsRed-nos1 30UTR or DsRed-TDRD7 30UTR), but
not green (coinjected GFP-vasa 30UTR) in PGCs (Figures
3B and S2B), indicating that Dnd1 affects gene expression
through the 30UTR of nanos1 and TDRD7. Next, we
examined whether the reduction in nanos1 and TDRD7
following loss of Dnd1 depends on the ability of miR-430
to interact with these genes. Both nanos1 and TDRD7
harbor one miR430-targeting site (Figures 3C and S2C).
We therefore compared the expression of marker genes
fused to a wild-type or a mutated miR-430-targeting site
in nos1 30UTR and TDRD7 30UTR. Quantitative pixel-inten-
sity analysis showed that the reduction in fluorescence
resulting from knocking down Dnd1 function was effec-
tively suppressed by mutating the miR-430-targeting site
(Figures 3C and S2C). Altogether, our data suggest that
Dnd1 functions to relieve miR-430-mediated nanos1 and
TDRD7 inhibition in zebrafish PGCs.
U-Rich Regions Mediate Dnd1 Binding
and Function
Dnd1 contains two single-strand RNA recognition motifs,
spanning approximately residues 60–131 and 140–213.
Our data suggest that these domains bind mRNAs at
specific sites. A BLASTP search of the Dnd1 sequence
against the database of known structures (the PDB)
revealed several significant homologs (E values of 105
and 103) and allowed straightforward homology-based
modeling using the SWISS-MODEL server (Schwede
et al., 2003). Superimposing the two homology-modeled
domains in the structure of the similar Drosophila sex-
lethal protein bound to uridine-rich single-stranded RNA
indicated clearly that Dnd1 has all the hallmarks necessary
to bind U-rich single-stranded RNA (Handa et al., 1999).
We therefore reasoned that Dnd1 might also bind U-rich
regions (URRs). Interestingly, two URRs are found in
between the two miR-221-binding sites in p27 30UTR
(Figure 4A, marked purple). To test whether the region in
between the two miRNA sites is sufficient to confer
Dnd1 activity, we cloned it into a luciferase reporter vector
(p27 30UTR(196–300)). Figure 4B shows that this minimal
region is sufficient to allow full repression by miR-221
and derepression by Dnd1. To more specifically address
the role of the URRs, we generated two mutants: mutant
1, in which the two URRs were replaced by non-URRs,
and mutant 2, where adjacent sequences were similarly
mutated as control. Importantly, mutating the URRs, but
not the adjacent sites, conferred resistance to the Dnd1Celleffect (Figure 4C). No significant change in the repression
activity of miR-221 was noted in mutant 2 (data not
shown), indicating that these mutations did not affect
miR-221-mediated repression of the p27 30UTR. To fur-
ther investigate the role of each URR, three more mutants
were produced where either URR 1 or 2 were mutated
(Figure 4A). Both mutants supported full Dnd1 activity
(Figures 4C and 4D), suggesting that Dnd1 requires at
least one URR adjacent to the miR-221 sites to function.
Next, we examined whether the URRs serve as docking
sites for Dnd1. We immunoprecipitated (IP) HA-tagged
Dnd1, Dnd1(Y104C), or control proteins from HEK293 cells
and incubated them with RNA purified from MCF-7 cells
expressing control vector, wild-type, or mutant 1 lucifer-
ase-p27 30UTR(196–300). As detected by RPA on the bound
material, a clear and significant enrichment of lucifer-
ase-p27 30UTR(196–300) was observed when wild-type
Dnd1-HA was used for the pull down assay (Figure 4E).
In contrast, no significant pull down of luciferase was
observed when the URRs of luciferase-p27 30UTR were
mutated (mutant 1) or with Dnd1(Y104C). The specificity of
the binding as well as the equal efficiency of pull-down
was demonstrated by absence of binding between Dnd1
and endogenous hTR, while equal precipitation of endog-
enous cyclophilin was seen in all extracts (Figure 4E).
Although we cannot rule out that mutations in URRs
have effects on the binding of other RBPs, our results sug-
gest that Dnd1 binds URRs and thereby mediates sup-
pression of miRNAs.
To test the in vivo relevance of URRs to Dnd1 function,
we mutated URRs found within the zebrafish nos1 and
TDRD7 30UTRs and tested the effect of these mutations
on gene expression. Figure 5A shows that mutating one
URR (mut3, downstream of miR-430 site) of nos1 30UTR
reduced its expression. Similar results were obtained
with TDRD7 30UTR (Figure S2D). To test whether the effect
of URR mutation was dependent on miRNA function, we
introduced the mutation of the URR in the background
of the miR-430 target-site mutant. Figure 5B shows that
mut3 did not reduce gene expression when miR-430 tar-
get site was mutated, suggesting that also in this case
Dnd1 effect is miRNA dependent.
Mechanism of Dnd1 Function
Our results point to a model by which Dnd1 positively
regulates gene expression by prohibiting miRNA-medi-
ated gene suppression. To test this model we examined
the direct interaction of miR-221 with its target p27 in hu-
man HEK293 cells, in the presence or absence of human
Dnd1. We designed a synthetic RNA duplex mimicking
miR-221where the sense oligo was taggedwith a 30-biotin
group for efficient pull-down using streptavidin beads. As
control, we used a seed mutated, biotin-tagged, miR-221(C) One-cell-stage zebrafish embryos were coinjected with RNA containing the venus open-reading frame fused to the wild-type nanos1 30UTR
(30nos1wt), RNA containing the cfp open-reading frame fused to the miR-430-binding site mutated nanos1 30UTR (cfp-30nos1mut1) and vasa-dsRed
(for labeling the germinal granule for easier identification of germ cells) together with dead endmorpholino or control morpholino. Error bars depict the
standard error of the mean (SEM); the p value was calculated using t test.131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc. 1279
Figure 4. Binding of Dnd1 to URRs Mediates Derepression of p27 Inhibition by miR-221
(A) A diagram aligning the sequence area in p27-30UTR containing the two miR-221 target regions. In red are regions mutated in the indicated
constructs.
(B–D) Luciferase reporter assay were performed as in Figure 1B using the indicated pGL3-p27-30UTR constructs and the expression vectors for
huDnd1 and miR-221. The results are represented as means and SD from three independent experiments.
(E) HEK293 cells were transfected with the indicated Dnd1-HA expressing vectors, and Dnd1 was IPed using anti-HA antibody. Immunoblot analysis
shows the expression and IP of Dnd1.MCF-7 cells were transfected with luciferase-p27-30UTR constructs; RNAwas extracted after 48 hr and equally
divided between the IPs. Beads were incubated with the RNA for 45 min at 6C, washed, and subjected to RPA using probes to detect luciferase and
cyclophilin mRNAs, and the noncoding human telomerase RNA (hTR).1280 Cell 131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc.
duplex. The activity of these taggedmolecules toward p27
30UTR was verified in a luciferase assay (Figure S3) and
Dnd1 toward p27 in western blot (Figure 6A, left). As
HEK293T cells express miR-221, exogenous introduction
of miR-221 results in only a slight effect on p27 expres-
sion, while introduction of human Dnd1 raises p27 levels
(see also Figure 1C). Subsequently, we examined whole-
cell extracts and pull-downs from the same cell popula-
tions using RPA and detected a specific association
between wild-type miR-221 and endogenous p27 mRNA
(Figure 6A, middle and right panels). No specific interac-
tion was observed with hTR, our negative control. Most
intriguingly, introduction of human Dnd1 completely abol-
ished the interaction of miR-221 with p27 mRNA, indicat-
ing that Dnd1 inhibits miR-221 accessibility. Collectively,
our results indicate that Dnd1 counteractsmiRNA function
by binding URRs in 30UTRs of mRNAs and reducing their
affinity to miRNAs (Figure 6B). However, we cannot ex-
clude at this point that additional functions, such as coun-
teracting RISC activity or subcellular sequestration, may
contribute to Dnd1 activity.
DISCUSSION
In this study we provide evidence that primordial germ
cells possess factors such as Dnd1 that protect the ex-
pression of several genes from repression by miRNAs,
as exemplified by miR-430. The expression of at least
some miR-430 RNA targets, such as nanos1 and
TDRD7, is allowed in primordial germ cells in the presence
of miR-430. Similarly, the expression of LATS2, a target
gene for the miR-372-family, is dependent on the expres-
sion of Dnd1 in Tera1, a human cell line derived from
a germ-cell tumor that contains high levels of the
miR-372 family. Our findings provide an explanation for
this phenomenon. We suggest that Dnd1 suppresses
miR-430 and miR-372-family function toward several of
its mRNA targets by binding to URRs that are located
within these mRNAs. Our results pinpoint the mechanism
by which Dnd1 exerts its function. Binding of Dnd1 to
mRNAs prohibits miRNA interaction.
Dnd1 in Germ-Cell Development
Both in zebrafish and in mouse, Dnd1 is essential for
germ-cell survival, whereas in the 129-mouse background
it induces testicular germ-cell tumors (TGCTs) arising from
the few germ cells that develop in the absence of Dnd1
(Weidinger et al., 2003; Youngren et al., 2005). These tu-
mors resemble human testicular germ-cell tumors, which
are the most common cancers affecting young men (Oos-
terhuis and Looijenga, 2005; Youngren et al., 2005). It
remains to be established which mutation(s) from the
129 strain synergize with the Dnd1 mutation to cause
the development of TGCTs. However, recently three pro-
tein-coding genes, from which two are RBPs and one
miRNA, were identified to be candidate disease genes
from the 129 strain (Zhu et al., 2007). Additionally, a recent
finding in C. elegans showed that disruption of the germCellplasm by loss of two genes involved in RNA biology in
these animals can also lead to the development of similar
tumors (Ciosk et al., 2006). Our results demonstrate that
loss of Dnd1 enhances miRNA repression of some genes
that are essential for primordial germ-cell development
(Koprunner et al., 2001) (among them nanos1 and
TDRD7) and predict that this mechanism can be responsi-
ble for defects in germ-cell survival or for tumor formation.
Whether protection of mRNAs from miRNAs is the only
function of Dnd1 in germ cells remains to be investigated.
Nevertheless, our results show that counteracting or bal-
ancing miRNA function is important during development,
at least to maintain viable and functional germ lines in
zebrafish and mouse.
Dnd1 and Other RBPs
Recent publications have implicated mechanisms that
counteract the activity of miRNAs on specific mRNAs
(Ashraf et al., 2006; Bhattacharyya et al., 2006; Schratt
et al., 2006). Together with these studies, our data unveil
a dynamic regulation of miRNA suppression on the
30UTRs of target mRNAs. The most relevant work showed
that HuR (ELAV1), an AU-rich element (ARE) binding pro-
tein, relieves CAT-1 mRNA from miR-122-mediated
repression, a process that involves binding of HuR to the
30UTR of CAT-1 mRNA (Bhattacharyya et al., 2006). The
mechanism of HuR action is yet unknown. Here, we iden-
tified Dnd1, another RBP, whose activity is comparable to
HuR. However, our results highlight several differences
between Dnd1 and HuR. While Dnd1 depends on URRs
to relieve the miRNA repression, HuR depends on
AU-rich elements. Second, Dnd1 seems to have a broad
effect, as we have strong evidence showing that the re-
pression of p27 by miR-221, LATS2 by miR-372, con-
nexin-43 by miR-1 and -206 (Anderson et al., 2006), and
Nanos and TDRD7 by miR-430 in zebrafish PGCs, are all
being antagonized by Dnd1; for now HuR seems to have
a more restricted function, suppressing CAT-1 expres-
sion. Last, the expression of HuR is induced following
stress in liver cells, whereas Dnd1 expression is restricted
to primordial germ cells and certain neuronal tissues
(Youngren et al., 2005). By binding to mRNA, Dnd1 pre-
vents miRNA-mediated repression. Whether this is a gen-
eral mechanism applicable to HuR, or other RBPs,
remains to be seen.
Counteracting miRNAs and siRNAs
Our work shows that Dnd1 activity can counteract gene si-
lencing induced by miRNAs but not by siRNA-mediated
RNA interference (RNAi). When one miR-221-targeting
site in p27 30UTRwas converted to a full miR-221 comple-
mentary sequence (Figure 2B) as well as when a fully com-
plementary shRNAwas used to target the 30UTR of LATS2
(Figure S4), Dnd1 function was lost. Since Dnd1 associ-
ates with mRNA and not with miRNAs, we can envision
two possibilities that could provide an explanation. (1)
Dnd1 binding could change the RNA structure to be unfa-
vorable for miRNA binding by, for example, enforcing131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc. 1281
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Figure 6. Mechanism of Dnd1 Function
(A) HEK293T cells (endogenously expressing miR-221 and p27) were transfected as indicated. Cells were harvested 48 hr later and subjected to pull-
down assay with streptavidin beads. Pull-down and whole-cell extracts were analyzed by immunoblot and RPA. Note, because HEK293T cells
endogenously express miR-221, only a moderate reduction in p27 level was observed upon introduction of miR-221 oligos, while Dnd1 expression
induced p27 expression. The results are represented as means and SD from three independent experiments.
(B) Schematic model depicting the mechanism of Dnd1 action. The miRNA-RISC loaded with miRNAs targeting a 30UTR inhibits its translation (upper
panel). By binding to URRs in the 30UTR, Dnd1 prevents miRNAs from binding to and inhibiting translation, thereby prohibiting miRNA function (lower
panel). CR is coding region.a secondary structure that hides the sequence required
formiRNA-seed recognition. As siRNAs do not entirely de-
pend on seed sequences and their association with
mRNAs is tighter, their binding to 30UTRs could therefore
be less affected. (2) Dnd1 could localize mRNAs to loca-
tions in the cell that are not accessible tomiRNA-mediated
silencing but still mRNA degradation by an RNAi-medi-
ated mechanism is possible.
30UTRs as Binding Platforms
for Regulating miRNAs and RBPs
Our results strongly suggest that the 30UTRs of at least
some mRNAs are binding platforms for both miRNAs
that repress translation and RBPs that regulate this re-
pression. In particular, RBPs can restore gene expression
in the presence of inhibitory miRNAs. This mode of regu-
lation has several consequences. First, as it affects proteinCellsynthesis and mRNA stability rather than controlling the
expression of miRNAs in the cells, it is potentially a very
rapid mechanism. Second, relief of repression can be
exerted simultaneously on only a subset of the miRNA-
targeted mRNAs, thereby giving modularity to miRNA
function. Third, it adds robustness to expression patterns
as different RBPs can in principle relieve the repression of
different sets of mRNAs, even if these are regulated by the
same miRNA. Fourth, this mechanism allows differential
gene regulation in different tissues while keeping the ex-
pression of both miRNAs and mRNAs constant in the
cell. One implication of this mode of regulation is that
the presence of a miRNA and its target in the same tissue
does not necessarily result in repression, therefore allow-
ing coexpression of both miRNA and target mRNA. How-
ever, how broad Dnd1 function is: how many mRNAs and
how many miRNAs are affected by Dnd1 remains to beFigure 5. URRs Are Required for Dnd1 to Efficiently Repress miR-430-Mediated Nanos Inhibition
(A) RNA containing the DsRed open-reading frame fused to the wild-type nanos1 30UTR (30nos1wt) was coinjected into one-cell-stage zebrafish
embryos together with RNA containing the gfp open-reading frame fused to different versions of the nanos1 30UTR. The different nanos1 30UTRs
that were used are shown above; mutations are marked in red. The ratio between the signal intensity provided by GFP whose open-reading frame
was fused to either one of the nanosUTRswas divided by that originating fromDsRed thatwas fused to thewild-type nanosRNAUTR. Representative
single cells are shown in the right panels.
(B) An experimental setting similar to that described in (A) was used to examine the function of nanosUTR containing a combination ofmutations in the
miR-430 and putative Dnd-binding sites. The different nanos1 30UTRs that were used are shown above; mutations are marked in red. The ratio
between the signal intensity provided dividing the signal intensity of GFP by that of DsRed whose open-reading frame was fused to the wild-type
nanos RNA UTR. Representative single cells are shown in the right panels. Error bars depict the standard error of the mean (SEM); p value was cal-
culated using Ttest.131, 1273–1286, December 28, 2007 ª2007 Elsevier Inc. 1283
elucidated. Our results indicate that several mRNAs and
miRNAs are potentially regulated by Dnd1. Genome-
wide proteome and RNome analysis comparing normal
cells to cells lacking Dnd1 may address these issues in
the future.
EXPERIMENTAL PROCEDURES
Constructs and Antibodies
miR-Vec constructs were described before (Voorhoeve et al.,
2006), and Dnd1 open-reading frames were cloned as described
(Weidinger et al., 2003) into a pCS2-based CMV expression vector
to contain a double carboxy-terminal HA tag. Dnd1 homologs ACF
(IOH52413.1), HNRPR (IRALp962F134.1), LOC-166863 (IRAKp961
H0534.1), and SYNCRIP (IRATp970H1055D) were similarly cloned
into this vector (sequences obtained from RZPD Deutsches Ressour-
cenzentrum fu¨r Genomforschung GmbH; Berlin, Germany). The PAK4-
HA expression vector was described (Wells et al., 2002). The 30UTRs of
p27 and connexin-43 were PCR amplified from genomic DNA and
cloned into pGL3 (Promega) downstream of the luciferase gene; con-
structs bearing the LATS2 30UTR were described (Voorhoeve et al.,
2006). The mutations in pGL3-p27mut-30UTR were cloned by PCR to
contain the following sequences from the original 30UTR from nt
183–282: GCCTCTAAAAGCGTTGGGGATCCCATTATGCAATTAGG
TTTTTCCTTATTTGCTTCATTGTACTACCTGTGTATATAGTTTTTACC
TTTTGGATCCCAC. In italics are the BamHI sites that substituted the
two seed sequences. The other mutants were similarly cloned to
contain the following sequences from nt 183–282; miRNA seeds
are shown in bold and mutations in italics. FC: GCgaaacccagcaga
caatgtagctTTATGCAATTAGGTTTTTCCTTATTTGCTTCATTGTACTA
CCTGTGTATATAGTTTTTACCTTTTGGATCCCAC; MUT1: GCCTCT
AAAAGCGTTGGATGTAGCATTATGCAATTAGGTgctcatggcTTTGC
TTCATTGTACTACCTGTGTATATAGTgctcatggcTTATGTAGCAC; MUT2:
GCCTCTAAAAGCGTTGGATGTAGCATTgctcatggcGGTTTTTCCTTA
TTTGCTTCATTGTACTACCTgctcatggcGTTTTTACCTTTTATGTAGCA
C; MUT3: GCCTCTAAAAGCGTTGGATGTAGCATTATGCAATTAGG
TTTTTCCTTATTTGCTTCATTGTACTACCTGTGTATATAGTgctcatggc
TTATGTAGCAC; MUT4: GCCTCTAAAAGCGTTGGATGTAGCATgtg
attgcgatgcgctcatggcggTGCTTCATTGTACTACCTGTGTATATAGTTT
TTACCTTTTATGTAGCAC; MUT5: GCCTCTAAAAGCGTTGGATGT
AGCATgtgattgcgatgcgctcatggcgggtgattgcgatgcgctcatggcgtatagttttta
ccttttatgtagcac. Constructs for RPA detection of hTR and cyclophilin
were described (Kedde et al., 2006), antisense probes for detection of
p27 (nt 340–577) and firefly luciferase (nucleotides 0–156) were gener-
ated by PCR, a T7 promoter sequence was included for labeling.
shRNA for pasha was described before (Gregory et al., 2004); the
shDnd1 sequence is GCAGCGACTTCGCCAGCAG—this was cloned
in pSUPER. All constructs were sequence verified.
Antibodies used were CDK4 (C-22), HA Y-11 (sc805), Cdc6 180.2
(sc9964) from Santa Cruz Biotechnology, Tubulin (YL1/2 ECACC),
and rabbit GFP.
Cell Culture, Transfections, and Dual
Luciferase-Activity Analysis
MCF7 andHEK293 cells were cultured in DMEMand Tera1 inMcCoy’s
5A supplemented with 10% heat-inactivated fetal calf serum in 5%
CO2 at 37
C. For protein-expression analysis and immunoprecipita-
tion HEK293 cells were transiently transfected using calcium-phos-
phate precipitation.
MCF7- and Tera1 cells were transfected using PEI (Polysciences,
Inc.) or Fugene (Roche), respectively, for luciferase analysis with
10 ng of reporter, 5 ng of renilla control plasmid, and 250 ng of either
miR-Vec or miR-Vec control, and 250 ng of either miR-Vec control or
expression plasmid for Dnd1 or homologs. Dual luciferase-activity as-
says were performed 48 hr after transfection according to the manu-1284 Cell 131, 1273–1286, December 28, 2007 ª2007 Elsevierfacturer’s directions (Promega). The results are represented as means
and standard deviation (SD) from three independent experiments.
Immunoprecipitation, Western Blotting, miRNA Pull-Down,
and RNase Protection Assays
Dnd1 was IPed from extracts of transfected HEK293 cells using Gam-
maBind G Sepharose (GE Healthcare). Extracts were made and beads
were washed with lysis buffer (125 mM NaCl, 50 mM HEPES (pH 7.5),
0,1% Nonidet P-40, 0.5% Tween-20, 10 mM MgCl2, and protease
inhibitor mixture [Roche Applied Science]). Interaction studies were
performed with total RNA from transfected MCF7 cells extracted
with Trizol reagent (Invitrogen) and split over IP samples in 50 ml lysis
buffer suplemented with RNase-OUT (Invitrogen). Reactions were
carried out for 45 min in an orbital shaker placed at 6C; thereafter,
beads were washed and RNA was extracted to be subjected to RPA.
For western blot analysis, extracts were separated on 10% SDS-
PAGE gels and transferred to Immobilon-P membranes (Milipore).
Western blots were developedwith Supersignal (Pierce) or ECL (Amer-
sham Biosciences) and exposed to film (Kodak). Cellular fractionation
was performed onMCF7 cells with NE-PER kits fromPierce, according
to manufacturer’s instructions.
Pull-downs with miRNAs were performed with miRNA oligos where
the sense strand contains a biotin group at its 30 end (Dharmacon) in
the mutant miRNA the seed (AGC UAC AUU) was mutated to AGG
AUC CUU. Cells were transfected with FuGENE (Roche) (150 nM
miRNA and 10 mg of control or Dnd1 vector) and after 48 hr lysed
in 20 mM Tris with pH 7.5, 200 mM NaCl, 2.5 mM MgCl2, 0.05%
NP40, 60U RNaseOUT/ml (invitrogen), 1 mM DTT, and protease inhib-
itors (Roche). miRNAs were pulled down with streptavidin sepharose
beads (GE healthcare) preblocked with yeast tRNA (Invitrogen) and
RNase free BSA, (Ambion), and washed four times with lysis buffer.
RNA was extracted and subjected to RPA.
RPAs for Luciferase, p27, cyclophilin, and hTR were performed
using the HybSpeed RPA and MAXIscript kits from Ambion as de-
scribed (Kedde et al., 2006). For miR-221 we used mirVana kits
(Ambion) according to the manufacturer’s instructions and the primer
GCAACAGCTACATTGTCTGCTGGGTTTCAGGCTcctgtctc. We used
2 mg of total RNA (2% of input) and half of IP samples per reaction.
Quantitative RT-PCR Analysis
RNA was extracted using Trizol reagent (Invitrogen), and cDNA (from
3 mg RNA) was synthesized with superscript III and primed with oligo-
dT according to manufacturer’s instructions (Invitogen). Primers for
zebrafish qPCRwere nanos1 For/Rev: AGACTGAGGCCGTGTACACC
TCTCACTACT / GAGCAGTAGTTCTTGTCCACCATCG, ODC For/Rev:
ACACTATGACGGCTTGCACCG / CCCACTGACTGCACGATCTGG,
vasa1 For/Rev: CCTGCTGCCTATCCTACAGC / CAGGTCCCGTATGC
AAACTT, TDRD7 For/Rev: TCTACCCAGCGGAAGCTTTA / CTGG
TGTCCCACTGGTCTTT. Primers for human Dnd1 were For/Rev: CT
CCACAGGCACCCTGAATG / GGTGCCATAGGTCCCTGTCC; other
primers were as described (Voorhoeve et al., 2006). Analyseswere car-
ried out using SYBR Green PCR master mix (Applied Biosystems) and
Chromo 4 system (BioRad Laboratories).
Zebrafish Strain and Fish Maintenance
Zebrafish (Danio rerio) of the AB genetic background were maintained,
raised, and staged as previously described (Kimmel et al., 1995; West-
erfield, 1995).
Morpholino Knockdown of Dnd1
The dead end morpholino antisense oligonucleotide (dnd MO, 50-GC
TGGGCATCCATGTCTCCGACCAT-30) and the standard control MO
were obtained fromGenetools, Philomath, OR. Six hundred picograms
were injected into one-cell stage embryos to efficiently knock down
Dnd1 function (Weidinger et al., 2003).Inc.
RNA Expression Constructs
Capped sense RNA was synthesized using the mMessageMachine kit
(Ambion) andmicroinjected into one-cell stage embryos. The following
constructs were used: pSP64T-mgfp-vasa-30UTR (GFP-30vasa in
Figure 3A) (Wolke et al., 2002), pSP64T-mgfp-nos1-30UTR (Koprunner
et al., 2001), pSP64T-vasa-dsRedEx-nos1-30UTR (Ds-Red-30nos1 in
Figure 3B), pSP64T-dsRedEx-nos1-30UTR, T3-venus-nos1-30UTR
(30nos1wt in Figures 3C and 5). To obtain a mutation in the miR-430-
binding site pSP64T-ecfp-nos1-30UTR was amplified using primers
(GTCTTTTTGTGTGTGTGTAT and CAAAATCAAACAGTGAACGC) re-
sulting in pSP64T-ecfp-nos1-30UTRmut1 (30nos1mut1 in Figure 3C).
To obtain a mutation in the putative Dnd interacting sequence 1
pSP64T-mgfp-nos1-30UTR was amplified using primers (CAGCA
CTTTTTGTGTGTGTGTATA and GCTCAAACAGTGAACGCACACAT)
resulting in pSP64T-mgfp-nos1-30UTRmut2 (30nos1mut2 in Figure 5).
To obtain a mutation in the putative Dnd-interacting sequence 2
pSP64T-mgfp-nos1-30UTR was amplified using primers (CAGTGTGC
ACTGGTGTTGTGTT and GCTAAAACACAGCAAACACACACA) result-
ing in pSP64T-mgfp-nos1-30UTRmut3 (30nos1mut3 in Figure 5). To
obtain a double mutation in both putative Dnd-interacting sequences
pSP64T-mgfp-nos1-30UTRmut2 was amplified using primers (CAGTG
TGCACTGGTGTTGTGTT and GCTAAAACACAGCAAACACACACA)
resulting in pSP64T-mgfp-nos1-30UTRmut2+3 (30nos1mut2+3 in Fig-
ure 5). To obtain a double mutation in the putative Dnd-interacting
sequence 2 and in the miR-430-binding site, pSP64T-mgfp-nos1-
30UTRmut1 was amplified using primers (CAGTGTGCACTGGTGT
TGTGTT and GCTAAAACACAGCAAACACACACA) resulting in
pSP64T-mgfp-nos1-30UTRmut1+3 (30nos1mut1+3 in Figure 5). To
obtain a triple mutation in both putative Dnd-interacting sequences
and in the miR-430-binding site, pSP64T-mgfp-nos1-30UTRmut2+3
was amplified using primers (GTCTTTTTGTGTGTGTGTAT and ACCT
GGCTCAAACAGTGAACGC) resulting in pSP64T-mgfp-nos1-30UTR
mut1+2+3 (30nos1mut1+2+3 in Figure 5). To obtain pSP64T-ds
RedEx-TDRD7-30UTR (30TDRD7 in Figures S2B and S2C), pSP64T-m
gfp-TDRD7-30UTR (30TDRD7wt in Figure S2D) and pSP6T-eyfp-
TDRD7-30UTR the 30UTR of TDRD7 (EF643554) was amplified using
primers (AAACTCGAGTACTCTCAGAACTGCACTTTC and AAATCT
AGATAATACAACAAAACCTGAACACC) and cloned into correspond-
ing vectors. To obtain a mutation in the miR-430- binding site
pSP64T-mgfp-TDRD7-30UTR was amplified with primer (TCTTTG
GTTTGTTTTGCTGTGTTT/CCAAAATCAAAAAGTACAAACAATG) and
subloned into an ecfp-containing vector resulting in pSP64T-ecfp-
TDRD7-30UTRmut1 (30TDRD7mut1 in Figure S2). To obtain a mutation
in the putative Dnd-interacting sequence 2 pSP64T-mgfp-TDRD7-30U
TR was amplified using primers (CAGCACTTTGGTTTGTTTGCT and
GCTCAAAAAGTACAAACAATGC) resulting in pSP64T-mgfp-TDRD
7-30UTRmut2 (30TDRD7mut1 in Figure S2).
Fluorescence Microscopy and Imaging of Live Cells
Images were obtained using a Zeiss Axioplan2 microscope controlled
by the Metamorph software (Universal Imaging). Average pixel inten-
sity in germ cells was measured and subtracted from the background
signal using the ImageJ software. Error bars represent the SEM. The
p values were calculated using t test.
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.cell.com/cgi/content/full/131/7/1273/
DC1/.
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